Determining when life begins is complicated by
a process that unfolds months before a sperm meets an
egg
By Stephen S. Hall
DISCOVER Vol. 25 No. 05 | May 2004 | Biology
& Medicine
Shortly
before 10:30 on a recent evening, with a nearly full moon
luminous through mile-high air, Jonathan Van Blerkom climbed
into his car, eased out of his driveway, and threaded his way
through a quiet Denver neighborhood to check on the fate of
some precious human eggs. They had been inseminated that
morning, and some of them should be one-celled embryos by now.
Van Blerkom’s day had begun more than 16 hours earlier, but
human development works the night shift, so Van Blerkom does
too. Every evening, weekends included, he sets out on this
five-minute drive to do one of the things he does best: look
at very early embryos, only hours after fertilization, to
decide if they are likely to become babies.
|

Courtesy of S. Makabe and Jonathan
Van Blerkom, “An Atlas of Human Female Reproductive
Function,” Taylor & Francis Books LTD., 2004.
|
The embryos had been incubating all day in a
small laboratory at Colorado Reproductive Endocrinology, a
private fertility clinic where Van Blerkom, a professor at the
University of
Colorado,
collaborates with in vitro fertilization doctors to help
increase the chances that infertile couples can have children.
He himself is not an “IVF doc.” He is a scientist with a
passionate, if not obsessive, curiosity about the biological
factors that allow an egg to create a human. Ironically, that
interest has also made him an expert in all the things that
can go wrong with an egg and doom a pregnancy—even before it
begins.
On
this particular night, Van Blerkom dropped in to check on the
status of eight eggs that were harvested that morning from a
persistently infertile woman and soon afterward mixed with her
husband’s sperm. The woman had undergone several previous
cycles of IVF at another clinic without a pregnancy, and Van
Blerkom wasn’t particularly hopeful about this round, either.
“She’s maybe a problem,” he said in his low, urgent voice as
he moved quickly about the lab.
Van
Blerkom—dressed in blue jeans and a blue button-down shirt, a
fringe of long graying hair sticking out like a worn-down but
beloved brush—took great pains to keep the eggs warm during
this nocturnal assessment. He turned on special heaters and
waited about 15 minutes until the filtered air under a
protective hood—where he would inspect the nascent embryos
under a microscope—had reached 95 degrees Fahrenheit. Then he
removed several small plastic dishes from the incubator and
began to peruse the eggs.
For
the better part of the past two decades, human embryologists
have been staring at eggs and early embryos trying to decide
which are “good” and which are not, which embryos seem most
likely to yield a viable infant after implanting and which are
destined to fail. These judgments have traditionally involved
more art than science, as befits a procedure with an overall
success rate of less than 34 percent. Van Blerkom has spent
the last 25 years trying to inject scientific logic into these
snap visual judgments, which last no more than 30 seconds.
Under
the microscope, these eggs appeared like dark dots in a field
of cellular clutter. “She has a couple fertilized,” he
remarked, removing the debris with a sharply pointed pipette.
Then he moved to a second, more powerful Leica microscope
attached to a video monitor. One by one, eight human egg
cells, as big as the moon that Colorado
night, loomed on the screen.
“This
is at 10 hours after insemination,” Van Blerkom said. “There,
you can see the pronuclei.” There on the screen was the huge,
rotund universe of the female egg cell, its internal jelly, or
cytoplasm, smooth and evenly grained, and there, just below
the equator, two ghostly yolklike circles around the male and
female DNA, mere mirages of genetic material, in close
proximity, nearly nuzzling. Each gamete—egg and sperm—prepares
its half packet of genetic material, known as the pronucleus,
and one of the first organizational tasks of human development
is to bring these two packets together. The glancing proximity
of the male and female pronuclei on the screen represented the
final stage of a daylong dance—a long latitudinal migration by
the sperm’s DNA to the site of the female pronucleus, so that
the male and female chromosomes can “approach each other and
melt into one,” as a 19th-century embryologist poetically put
it. That produces a complete set of human chromosomes and
leads to the first division of the cell.
Even
though the first several embryos looked smooth and even, Van
Blerkom wasn’t optimistic. “She doesn’t have great stuff,” he
said. When asked how he could tell, he replied, “Just by
looking at the quality of the cytoplasm in the unfertilized
eggs. This is in pretty bad shape. These are not normal
eggs.
“Look
at this one,” he continued. “This one has a lot of
disorganization in the cytoplasm.” And indeed, as more of the
eggs filled the screen of the monitor—some fertilized, most
not—the cells frequently had large vacuoles, or fluid-filled
bubbles, in their interior. From experience, Van Blerkom knew
that, although such eggs may become fertilized, they rarely
produce a successful pregnancy. There is even a hint of
evidence that normal-looking eggs from a woman who also has
these abnormal eggs may fail to yield offspring.
“You
look at these eggs, and you know they’re telling a story,” Van
Blerkom said later. “But you only know bits of the story. If
it were an abstract notion, who’d care? But around the world,
thousands of people are looking down microscopes at thousands
of eggs and asking, ‘Should I keep this?’ So life-or-death
decisions for the one-celled embryo are made every day. My
argument is, let’s make those decisions based on biology.”
For
more than 20 years, Van Blerkom has been trying to understand
the story that egg cells are telling, and although the tale is
far from complete, some compelling new clues to early
development have emerged. As both an academic studying the
basic biology of mammalian development and as an IVF
consultant with access to human egg cells and human embryos
for research purposes, he is one of just a few scientists in a
position to push a revolution in thinking about how—and
whether—life begins. It involves the way an egg cell is built
and how information positioned during that construction
affects the fate of the embryo.
Scientific
study of this phenomenon, known as polarity, could reveal how
the fate of a human embryo may be shaped—and predicted—by
extremely early biological events that predate conception by
days, weeks, or even months. Surprising new research findings
by Van Blerkom and others raise the paradoxical possibility
that the viability of life may be determined long before
fertilization.
The
notion of polarity is quite simple. If you imagine the female
egg cell (and later, the fertilized egg) as a spherical planet
with its own intrinsic biological geography, then certain
characteristics of that cell—the location of protein molecules
or RNA messages or biochemical traits like pH or even the
internal connective structures called microtubules—will be
more prominent in certain regions, like one hemisphere as
opposed to the other, or near the surface rather than near the
core. Polarity of this sort has been known for a long time in
the embryological development of simple animals like frogs and
fruit flies. For just as long, it was not thought to be
relevant to development in mammals.
But in
the past few years, prominent British embryologists have shown
that polarity exerts tremendous influence on the early
development of mouse embryos. And several biologists in this
country are pushing the idea of polarity in human development
to more extreme conclusions. They argue that the fate of an
embryo depends on the way the egg organizes itself, and that
polarity in the egg can ordain either a successful or failed
pregnancy before
conception. This has profound implications for our
understanding of life’s origins, for our understanding of why
so many embryos spontaneously abort in the first few days
after fertilization, and for our understanding of why some IVF
procedures may subtly affect early development, with potential
long-term health consequences.
Most
of all, it means that the scientists who study human
development are increasingly looking at deep time, at events
that shape the human embryo well before fertilization. The
momentum of research, said Van Blerkom, is pushing embryology
back into the realm of cell biology, because the fate of the
organism is so inextricably tied to the quality of one cell
above all: the egg. “In mammals,” he said, “these are things
that are too important to be left to chance.” And so they are
built into the eggs.
Back
in the 17th century, when British physician William Harvey
made his famous observation “ex ovo omnia” (“from
the egg, everything”), natural philosophers believed that
human development derived entirely from the egg. The sperm, in
size as well as in deed, was puny by comparison. The most
recent research confers molecular respectability upon
Harvey’s old
maxim. Contrary to the message of 20th-century genetics, the
success of the embryo may have less to do with embryonic genes
than with maternal proteins passed on by the mother, and less
to do with the embryo’s DNA than with the maternal dowry the
egg brings to conception.
The
basic time course of fertilization and early development has
been known for decades. When a sperm cell meets an egg cell
(the oocyte), it burrows through the thick outer rind
surrounding the egg (the zona pellucida), enters the internal
cytoplasm of the egg (the ooplasm), and locomotes its male
DNA—half of the typical number of chromosomes—to the female
half within about three to four hours. During this microscopic
odyssey, the sperm undergoes tumultuous transformations, using
some as-yet-unknown materials in the cytoplasm to build a
“beacon” to find the female pronucleus, its head of DNA
swelling some five times its original size and then later
condensing into chromosomes at the end of the journey. “The
cytoplasm,” Van Blerkom said, “dictates what the sperm
does.”
Once
the two packets of DNA meld into one complete set of 46
chromosomes, the one-celled embryo begins to cleave, or
divide, becoming a two-celled embryo at around 22 to 28 hours
after fertilization, four cells another day later, and eight
cells around day three. Only then do the embryo’s own genes
fully kick into gear and begin to function. Because these
cells are grouped in a loose, pebbly collection resembling a
berry, this stage of the embryo is referred to as the morula
(from the Latin for “little mulberry”). Around the fourth day,
however, the 15-to-25-celled mulberry dramatically tightens
and seals its connections with neighboring cells (a process
called compaction) and begins pumping fluid into its internal
cavity. Now known as a blastocyst, the embryo undergoes a
dramatic division of cell fate, forming a distinct outer layer
of cells and an equally distinct bulge of about 20 or 30 cells
on the inside. The outer cells (the trophectoderm) become the
placenta; the inner bulge of cells includes embryonic stem
cells, destined to form the entire fetus. Usually by the sixth
day after fertilization, the blastocyst will hatch out of the
egg cell’s still-resilient rind and attach to the
uterus.
|
Changes of
Living to Birth
378 DAYS BEFORE
BIRTH
(~.005%)
IMMATURE EGG
Three
months before each ovulation, possibly 20 egg cells
begin to develop in an ovary of a healthy woman of prime
childbearing age (18 to 24 years old). Normally only one
egg survives and is released through a follicle that
rises to the surface of an
ovary.
268 DAYS BEFORE
BIRTH
(~11%)
OVULATED
EGG
A mature
egg begins a 5 to 6 day trip through the fallopian tube
toward the uterus. It can be fertilized during a period
of 12 to 48 hours after its release. If a woman has sex
during this time frame, some scientists say, the odds of
fertilization are one in
three.
266 DAYS BEFORE
BIRTH
(~33%)
FERTILIZED EGG
Half the
number of eggs that are successfully fertilized through
artificial insemination survive to be implanted. Some
scientists speculate that the survival rate is similar
for natural pregnancy, but other scientists argue that
this cannot be
determined.
262 DAYS BEFORE
BIRTH
(~66%)
IMPLANTED
EGG
Once an
egg implants itself in the uterus, it has a three in
four chance of developing further. An embryo may abort
even before the woman knows she is pregnant. Half of
these natural abortions result from chromosomal
abnormalities in the
egg.
241 DAYS BEFORE
BIRTH
(~88%)
FIRST
TRIMESTER
Three
weeks after implantation of the egg, body parts begin to
develop rapidly. At this stage, 1 in 10 embryos are lost
due to chromosomal defects or a variety of external
factors, including malnutrition and the mother’s
exposure to toxins or
diseases.
178 DAYS BEFORE
BIRTH
(~97)
SECOND
TRIMESTER
From the
third to the sixth month of a pregnancy, roughly 2 out
of 100 fetuses don’t survive. Most losses are less
likely to be due to defects in the fetus itself than to
maternal problems, such as a weak cervix, a faulty
uterus, or malformations of the
placenta.
89 DAYS BEFORE
BIRTH
(~99%)
THIRD
TRIMESTER
Developmental biologists and doctors will
treat a fetus in the last three months of a pregnancy as
a patient on whom various diagnostic and therapeutic
procedures may be performed, increasing the already
promising odds of
survival.
BIRTH
(~99.9%)
NEWBORN
The
death of a full-term baby at birth is rare. Occasionally
babies die due to umbilical cord accidents, trauma, or a
pregnancy that extends more than four weeks past the
normal nine months. But national statistics are not
compiled for such deaths.
—Susan
Kruglinski |
The
intricacy with which an early embryo divides, compacts,
hatches out of the zona pellucida, ingeniously secretes
molecules that penetrate the cells lining the uterine wall in
order to implant in the womb, and then recruits blood vessels
to nourish the placenta and the developing fetus marks one of
the most awe-inspiring metamorphoses in all of
nature.
But
here’s the rub: It’s horribly inefficient in
humans.
Much
more often than not, the process fails. Although the
statistics on the failure rate of human fertilization are not
entirely robust, given the biological and ethical delicacy of
conducting research in this area, the numbers consistently
suggest that, at minimum, two-thirds of all human eggs
fertilized during normal conception either fail to implant at
the end of the first week or later spontaneously abort. Some
experts suggest that the numbers are even more dramatic. John
Opitz, a professor of pediatrics, human genetics, and
obstetrics and gynecology at the University of
Utah, told
the President’s Council on Bioethics last September that
preimplantation embryo loss is “enormous. Estimates range all
the way from 60 percent to 80 percent of the very earliest
stages, cleavage stages, for example, that are lost.”
Moreover, an estimated 31 percent of implanted embryos later
miscarry, according to a 1988 New England Journal of
Medicine study headed by Allen Wilcox of the National
Institute of Environmental Health Sciences.
In
some respects, less scientifically sophisticated cultures may
have come to terms with this conundrum in the way they
grappled with the knotty question of when life begins. The
medieval etymology of the word conception, said
Harvard biologist John Biggers, traces it to the Latin root capio, which means to
grasp, take hold, or receive into the body. In 1615 an obscure writer named
Cooke noted, “Conception is nothing els but the wombs
receiuing and imbracing of the seede,” suggesting that
centuries-old notions of conception referred, perhaps wisely,
to when an embryo survived its perilous first week and was
“imbraced” by the womb.
Nonetheless,
the high failure rate begs challenging ethical questions. If
life begins at conception, as many believe, why are so many
lives immediately taken? If, as some ethicists argue, nascent
life must be protected, how do we assess the degree of moral
entitlement due a nascent entity that fails to pass nature’s
own muster perhaps 80 percent of the time? And if the fate of
an organism is indeed inscribed in the earliest biological
inklings of an egg, does life begin with the
gametes?
From a
purely scientific, not to mention pragmatic, point of view,
the main question is more straightforward: Why do so many
embryos fail to grasp the womb? That question has bedeviled
developmental biologists for decades, and more recently, it
has vexed clinicians who practice assisted reproductive
medicine. Studying early human development in the academic
setting is extremely difficult, in part because of political
constraints on embryo research in the United
States, so a
certain amount of our knowledge is limited to inferences from
animal studies.
Nonetheless,
it has become increasingly clear that the fate of an embryo
may be cast in the ovarian follicles, where egg cells are
built. “Much of the developmental biology and ability of the
human embryo is determined even before it’s fertilized,” Van
Blerkom said. “This all happens by the one-cell stage, which
is when the fate of the embryo is determined.”
Such
thinking upends long-held assumptions in the world of biology.
Mammalian development was once thought to be essentially
different from embryological development in fruit flies,
frogs, worms, and other laboratory organisms, where
well-defined polarities in the egg—higher concentrations of a
protein in one part of the egg than in another, for
example—ordained such fundamental aspects of body plan as head
and tail, or back and belly. Mammals seemed exempt from these
rules for building a body. In the mouse, it had been shown in
the 1970s and 1980s that if you split an embryo at the
two-cell stage, each resulting cell had the ability to develop
into a full organism. If the egg were indelibly etched with
asymmetric information that unequivocably determines
development, the argument went, how could two embryonic cells
be separated and still produce whole, intact, normal
individuals? “Animal experiments led to the conclusion that
mammalian eggs do not have polarity, but I think that’s a huge fallacy,” said
David Albertini, a developmental biologist at Tufts
University in
Boston. One
possible answer, he added, is that mammalian embryos are
similarly shaped by polarity but retain a certain
developmental flexibility as well.
These
days, as biologists like Van Blerkom, Albertini, and a superb
school of
British
embryologists based in Oxford and
Cambridge have
started to look at the early embryo, they have begun to
catalog a number of very early polarities that affect both the
competence of the egg and the form of later embryonic
development. The implications of polarity reverberate far
beyond the confines of academia. For example, Van Blerkom and
Albertini have a gentlemanly disagreement about recent
research that may spill out into the public discourse soon
because it raises the possibility that some popular IVF
techniques might have subtle but long-term health implications
for children conceived in a dish. Indeed, on the night that
Van Blerkom inspected the fertilized eggs at the Denver
clinic, he made this disagreement clear at one point by
holding up a sharp micropipette for my benefit. He remarked
over his shoulder, “This is what I use to take off the cells
that David Albertini says I shouldn’t take off.”
And
with that, he began prying away the granulosa cells clinging
to the eggs, in order to get a better microscopic view of the
nascent embryos to see if they were developing properly.
Within three days or so, those denuded embryos would be
implanted in a woman’s womb.
The Sperm
Cell
Polarity begins in the sex
cells. The female egg cell is a huge biochemical universe unto
itself, with a complex and sophisticated cytoplasm. The sperm
cell, by contrast, is little more than DNA strapped to an
outboard motor. Nonetheless, of the 15 percent of couples
experiencing infertility problems, about half the trouble can
be traced to the male, mostly in the genetic qualities of the
sperm.
Immature sperm cells form
during the fourth week of embryological development but remain
unfinished until puberty. At that point, the male begins to
churn out haploid sperm cells—that is, sex cells with half the
normal complement of 46 chromosomes. Thus, when a sperm cell
delivers its genetic cargo at fertilization, the one-celled
egg again possesses the full 46 chromosomes. Sperm dysfunction
can arise from the way these cells are built. The sperm has an
acrosome (the head and sheath), a nucleus, and a tail.
Sometimes a club-shaped profile on the head disturbs the
proper construction of the tail. These tail abnormalities can
include looping, folding, and fusion, all of which can result
in reduced motility (ability to swim).
While assisted reproductive
techniques such as intracytoplasmic sperm injection
(ICSI)—which involves the direct injection of sperm into the
egg cell—can overcome head or tail abnormalities in sperm,
recent animal research suggests that fertility doctors must
use these techniques with care. Abraham Kierszenbaum of the
City University of New York Medical School has conducted
experiments in mice showing that even normal-looking sperm
from a mutant mouse “is likely to create infertile offspring.”
Hence, selection of donor sperm, he said, cannot be based on
appearance alone.
Biologist Jonathan Van
Blerkom of the University of Colorado published a paper in
1996 suggesting that some cases of male infertility derive
from defects in a tiny structure in the sperm cell called the
centrosome. When a sperm penetrates the egg, it unwraps the
centrosome, an organelle that acts like a construction foreman
overseeing the creation of microtubules in the cell. Sperm DNA
uses these microscopic highways to find the female DNA and
merge into a zygote. If a sperm has centrosome defects, Van
Blerkom speculates, it can get inside the egg but then is
destined to wander in the desert of the egg’s cytoplasm,
unable to find its way to the female’s DNA.
—S. S.
H.
|

Courtesy of Jonathan
Van Blerkom
|
While the debate over polarity is much more sophisticated
these days, it is not entirely new. In the late 1930s and
1940s, Arthur Hertig, John Rock, and several colleagues did an
experiment in human embryology that to this day remains
without peer in terms of elegance, revelation, and chutzpah.
Working at the time as a researcher at the Free Hospital for
Women in Brookline, Massachusetts, Hertig persuaded eight
women scheduled to have hysterectomies to record intimate
details of their lives prior to the surgery to remove their
wombs, including when they menstruated and had sex. Armed with
such precise information, Hertig’s research team found
developing embryos in either the fallopian tubes or uteruses
of the women and, adapting the headlight from an automobile to
illuminate their work, took photographs of early,
preimplantation human embryos. Not only were they able to
estimate when fertilization had occurred and also plot the
time course of early human development, they also made an
astonishing discovery: Half the embryos were clearly abnormal.
This was the first concrete hint that most human embryos fail
during the first week of development. Among other things, the
paper that Hertig and Rock published in 1954 contained some of
the first micrograph images of a human embryo at the
two-celled stage. Hertig expressed the hunch that one of those
cells was destined to be placenta, the other the developing
organism.
Throughout
his distinguished career (he headed the department of
pathology at Harvard
Medical
School for
two decades), Hertig suspected that there was a very early
commitment by embryonic cells to become either a fetus or the
placenta. He continued to explore this idea after his
retirement, when Harvard set him up in an animal laboratory in
the central Massachusetts town
of Southborough to
continue embryological research in monkeys. In the mid-1960s,
the lab hired a teenager from nearby Hudson for a
summer job cleaning out animal cages, and Hertig filled the
kid’s ears with his theories. “I had no idea who this guy
was,” the teenager would later say. “But he took me under his
wing, and by the end of the summer, the guy is teaching me
about ovaries and eggs.”
A
print of that first micrograph of a two-celled human embryo is
now framed and hangs on the wall above the desk in David
Albertini’s small, crowded office at Tufts
University
where, 30 years after he cleaned the monkey cages in
Southborough, he conducts research trying to figure out how
the fate of those two cells is determined. The search keeps
leading back to the mother’s eggs. “You can’t produce a
healthy human unless you produce a healthy egg,” said
Albertini. “What endows a healthy egg, and thus a healthy
embryo?”
In
some respects, a human egg takes a lifetime to mature. Each
female possesses up to 2 million oocytes at the time of birth,
but that number is winnowed down to about 250,000 by puberty.
Roughly 400 of these unfinished oocytes will mature and be
ovulated during a woman’s reproductive years, although the
quality of the finished eggs declines as she ages. The vast
repository of egg cells remains shelved in the follicles until
the brain sends a signal in the form of monthly bursts of
hormones, which trigger the final maturation cycle. From that
signal, it takes approximately 110 days for an egg to grow,
mature, and finally be released from the follicle.
In the
late 1980s, Albertini’s group began to focus on a group of
satellite cells that surround the oocyte as it begins to grow
and mature in the follicle. As eggs develop, each one is
surrounded by a herd of much smaller hangers-on. These are
called granulosa cells, and under the microscope they look
like grapes glued to a beach ball. Albertini and his
colleagues noticed that the interaction between the oocyte and
the cells surrounding it was not symmetrical; there were more
cells—and, it would turn out, more molecular back-and-forth
traffic between the egg and the granulosa cells—at certain
regions on the egg.
“We proposed that these cells
on the outside were imposing an asymmetry on the egg,”
Albertini said. The pattern, originally identified in rodents,
has now been shown to be true of cows, rhesus monkeys, and as
of three years ago, humans. “Almost all animals build an egg
in the ovary and position molecules in the top and bottom.
This is a highly conserved evolutionary mechanism to make sure
that when the cell gets subdivided, the cells at the top will
become the head, for example, and the cells in the back may
become a gonad. So you basically have to lay that down in the
egg. And then you’re just carving up the pie. We’ve been the
first to have evidence to support that in the mammal, though
not in the human yet. And there is evidence in human eggs,
from Van Blerkom and others, that molecules are
partitioned.”
Unlike
Van Blerkom, who has regular access to human eggs and embryos
through his IVF-related work, Albertini works primarily with
mouse and primate cells. But his lab’s animal studies have
revealed that asymmetry in an immature egg is important to the
development of an embryo.
Through
a series of elaborate experiments with mice, Albertini and his
colleagues at Tufts have shown that the small cells bunched
around an egg cell in the follicles are not mere microscopic
groupies. They form connections, known as gap junctions, that
send tendrils much like plumbing lines into the egg. The
plumbing analogy is apt because molecules flow into and out of
the egg through these channels. The molecules are critical to
normal development: When the genes for certain of these
molecules are experimentally erased, the eggs made by female
mice are invariably defective, and the errors fatally disrupt
the normal choreography of egg maturation.
Moreover,
Albertini’s group is exploring whether these plumbing lines,
which corkscrew into the outer rind of the egg, play a role in
establishing one of the most important geographic landmarks in
the life of an egg cell—an event, Albertini likes to say when
lecturing medical students, that marks “one of the most
important days in your life.”
“When
you build a big round cell,” Albertini said, “where do you put
its nucleus? In most animals, you anchor it to one side, and
that sets up all sorts of polarity.” This happens early in the
maturation of an egg cell, he argued, and is shaped by the
position of the cells surrounding the egg.
|

Courtesy of S. Makabe and Jonathan
Van Blerkom, “An Atlas of Human Female Reproductive
Function,” Taylor & Francis Books LTD., 2004.
|
When an egg cell matures, it must reduce its complement of
DNA by half. This parceling process, called meiosis, occurs
twice in the egg cell—once during a woman’s fetal development
and a second time as the egg is released from the ovary.
During the initial phase of meiosis, as a woman’s egg cell
reduces its number of chromosomes from the normal 46 to the 23
found in sex cells, it parks one expendable sack of halved DNA
in a spot near the cell surface. This is called the first
polar body, and it defines one of the earliest discernible
landmarks in the developing egg. This so-called animal pole is
where the primordial nucleus of the one-celled embryo is
destined to form. Just prior to ovulation, as the egg begins
its second round of meiosis, it creates a spiderweb trace of
proteins called the spindle, which allows the chromosomes to
separate properly and is critical to a successful pregnancy.
Spindle defects are believed to be the leading cause of the
chromosomal abnormalities that doom so many early embryos.
Albertini’s
group now suggests not only that these outside cells tell the
egg where to locate the polar body—and, therefore, the nucleus
and spindle—but also that their plumbing lines soften up the
egg cell’s rind in the opposite, or vegetal pole, to increase
the odds that sperm will penetrate the hemisphere opposite the
nucleus. “We were able to study, in human oocytes, where the
chromosomes were in relation to the polar body,” Albertini
said. “If the egg is born with an animal and a vegetal pole,
the polarity must have come from the ovary because that’s
where the egg is built. The somatic cells [those outside the
egg] may impose that axis. There are more cells, more
connections on one side of the egg than on the other.
Basically, what we’re finding is that the side the nucleus is
on has little contact with outside cells, and the further you
move from the nucleus, the more connections you see.” He
believes that this sets up the internal organization of the
egg’s cytoplasm.
In
fact, Albertini has preliminary evidence suggesting that the
communication between the egg cell and its surrounding
granulosa cells rises and falls in a precise monthly cycle.
Since the monthly spike of a follicle-stimulating hormone
seems to dampen the information exchange, he is now exploring
the possibility that each ovulatory cycle not only releases a
mature oocyte but also uses the monthly burst of female
hormone to adjust the compass of polarity in the eggs that are
still growing and will be ovulated one, two, or three months
later. “We can only extrapolate to humans, but in the mouse,
our data show that the whole process [of egg maturation] takes
18 to 20 days, and we can detect this asymmetry by the second
or third day of the process. In humans, as an extrapolation,
I’d predict that it would emerge between day 10 and day 20 in
a 100-day process prior to ovulation—three full reproductive
cycles before that egg would be used.” If this preliminary
hint holds up, the implications for maternal health become
significant. Well before a woman attempts to become pregnant,
she may be exposed to environmental effects—diet, prescription
drugs, alcohol, and various toxins—that could affect the
construction of her eggs. “Do you remember what you were doing
three months ago?” Albertini asked.
The
Albertini research, while pushing the starting time earlier,
joins an emerging body of research establishing the impact of
polarity on embryological development. In 2001 Magdalena
Zernicka-Goetz and her colleagues at the Wellcome/Cancer
Research UK Institute at the University of Cambridge did a
clever experiment in which they dissolved colored dyes in
olive oil and then stained each of the cells of a two-celled
mouse embryo a different color—one blue and the other pink. As
the embryo developed, the cells of the inner cell mass and the
developing organism were predominantly pink while the cells of
the developing placenta were blue, suggesting that
developmental fate may have been etched into these cells from
the moment of their very first division. This was, in a sense,
a possible molecular answer to the hunch about early mammalian
fates voiced by Arthur Hertig of the two-celled embryo half a
century earlier.
Embryology
has come a long way since those black-and-white images by Hertig. Van
Blerkom has, among many other things, elevated the biology of
human conception to high art. His lab in Boulder is
filled with spectacular pseudocolor images that are every bit
as dramatic as the peaks of the Front
Range,
which practically begin at the door to his office. The images
depict what might be called embryology in flagrante:
micrographs of sperm cells, trailing accordion-like pleats of
white zags as they streak across a vast blue ocean of ooplasm;
a multihued blastocyst in the process of hatching out of the
egg’s zona pellucida; and egg cells with a fringe of glowing,
fate-determining proteins, looking a bit like a solar eclipse
inside a cell.
These
are more than just pretty pictures. Ever since the 1970s, when
he worked in England with the developmental biologist Martin
Johnson, Van Blerkom has sought ways to analyze, and
visualize, secret compartments and regions of the human egg
that may offer clues to whether it is endowed with good
fortune or bad. “So many embryos don’t work in the human,” he
remarked one day, in the midst of a six-hour conversation.
“Why do so many go wrong? How does it go wrong? And how can
you use that information? All of this stuff is going to come
back to polarity. Human eggs that don’t develop normally may
be an issue of polarity.” Asymmetries and polarities in both
the cytoplasm and nuclear organization, Van Blerkom
discovered, begin to appear even before fertilization. “It’s a
huge cell!” Van Blerkom said. “It’s a 100-micron cell. And we
know there are different things going on in different parts of
the cell. There’s incredible shuttling within the cells. How
does that happen?”
Like
Albertini, Van Blerkom sensed that the most important
information in the embryo was not confined to the nucleus but
embedded in the cytoplasm. “If I’ve done anything in this
field,” he said, “it’s to deemphasize the embryo and emphasize
the egg cell. Our work has shown that it all begins with the
oocyte, which can have subtle cytoplasmic defects that are
actually very profound. But,” he added hastily, “you have to
be careful. It’s like looking at canals on Mars. Unless you
can show a consistent pattern [of polarity] and then an effect
that is different as cells divide, it doesn’t have
meaning.”
Van
Blerkom had been seeing hints of polarity since the 1970s, but
one of the major turning points occurred in 1996 when, by
accident, his lab discovered that cells surrounding the
developing egg—the same granulosa cells that had piqued
Albertini’s interest—possessed a receptor very similar to the
leptin receptor. Leptin made front-page news when it was
discovered in 1994 because the molecule appeared to regulate
fat metabolism and obesity. What was it doing in egg cells?
The
Colorado lab
discovered that granulosa cells—the cells that surround
maturing eggs in the ovarian follicles—were pumping out leptin
and shipping it into the egg. What’s more, the researchers
showed that leptin is polarized in the egg in such a way that,
after fertilization, the protein is allocated primarily to the
cells that become the placenta, while it is virtually
undetectable in the cells destined to become the fetus.
At
first, many embryologists resisted the notion that leptin was
segregated in certain parts of the egg and that this asymmetry
had any significance for the fate of the embryo. “For a long
time, no one believed it,” Van Blerkom said. But mice in which
the leptin gene has been erased are incapable of producing
embryos—the fertilized eggs die almost immediately. And
various experiments tracking leptin inside the mammalian egg
clearly showed a more prominent distribution in one hemisphere
than in the other. It is now believed that this protein acts
as a delayed silencer; it hangs around in the egg and keeps
certain genes from turning on in certain parts of the embryo
until days after fertilization. Again, the appearance of a
protein in a certain part of the egg cell may affect embryonic
development or the formation of organs days and weeks
later.
Lately Van Blerkom has been intrigued by another
form of polarity: the way mitochondria, the cell’s little
power plants, migrate in the maturing egg cell. “It’s kind of
like a lava lamp,” he says, “with these blobs of cytoplasmic
elements moving up and down in the cell.” Typically,
mitochondria arrange themselves along the outer edge of the
egg cell. But at certain points in the reproductive cycle,
they migrate en masse toward the nucleus. Wherever they
gather, mitochondria change the local chemical
microenvironment: They cause a lower pH, and that small
change, Van Blerkom believes, can affect the local activity of
certain enzymes. “It’s not a bag of cytoplasm,” he said. “It’s
highly structured, and that structure is changing.”
Finally,
Van Blerkom has conducted extensive work on the internal
structural organization of the human oocyte. First the oocyte
constructs the scaffolding of connections known as
microtubules, which allow molecules to move around inside the
cell. Then, toward the end of fertilization, the egg provides
a kind of highway that allows the sperm to make its final
approach to the female pronucleus. “There’s something in that
cytoplasm that allows the sperm to know where it’s going,” he
said. One of the compelling messages—and central paradoxes—to
emerge from these studies of polarity is that even bad eggs
can be fertilized to create an embryo, but only good eggs seem
to create a successful pregnancy. The politics of embryo
research, however, is one reason we don’t know more about what
distinguishes good eggs from bad. Federally funded research on
human embryos, although sanctioned by a congressionally
mandated national bioethics commission in 1975, has faced
unrelenting opposition from right-to-life groups. In 1996
Congress banned NIH funding outright for any research in which
an embryo is destroyed. Van Blerkom calls the issue of when
life begins the “third rail” of developmental biology. “You
can find whatever you want in the embryo to support any
position you have on when life begins,” he said. “A lot of
people believe that life begins at conception. But life also
ends at conception or shortly thereafter—hours after, a day
after, four or five days after. We don’t know why that
happens, and what’s gone wrong. We’d like to know the answers
to those questions,” Van Blerkom said, “but we can’t do those
experiments.”
If
polarity and the forces that shape it play a determining role
in the fate of a human egg, it’s not difficult to see the
implications for making babies, whether through assisted
reproductive technologies or the old-fashioned way. It becomes
a particularly nettlesome question because basic research of
the sort done by Van Blerkom and Albertini has historically
been adapted—snatched, really—for use in IVF clinics, often
before all the biological ramifications are clear.
Indeed,
this is where the polite disagreement between Albertini and
Van Blerkom becomes a matter of intense public and medical
interest. If you believe, for example, that granulosa cells
and other very early features of ovarian ecology set up the
polarities that ultimately determine the quality of a human
egg, as Albertini does, then certain techniques widely used in
IVF may be subtly perturbing the very mechanisms that eggs use
to establish a plan to build an embryo and maximize the
chances that it will develop properly. “We recognized in the
1980s that many culture techniques used by assisted
reproduction were reducing the quality of those eggs,”
Albertini said. “My own skepticism has been growing that we
therefore may be damaging things with what we’re doing to
these eggs prior to embryogenesis.” Other researchers—notably
Alan Handyside in England—have
begun to express similar concerns.
Albertini
cites a popular IVF technique known as intracytoplasmic sperm
injection, or ICSI, in which sperm is injected by needle right
into the middle of an egg cell. If his polarity research in
mice is true for humans, with its suggestion that sperm are
biased toward entering the egg at the opposite pole from the
cell’s nucleus for important reasons, then ICSI injections
might subtly disrupt patterns of polarity in the egg.
Moreover, ICSI requires the removal of the cells surrounding
the egg; Albertini thinks that might deprive the egg and early
embryo of important signals or alter the time course of
fertilization. Several rare, so-called imprinting disorders,
including Beckwith-Wiedemann syndrome, a form of gigantism,
have been found in children produced by ICSI, although the
extent and significance of these links is unclear. “Ten years
ago, we wouldn’t have thought about the polarity thing,” said
Albertini. “It wasn’t even on the radar. But now we’re looking
at how we’re making these babies.” Albertini hastened to add,
“I’m certainly a proponent of human-assisted reproductive
medicine, but I’m concerned that we’re rushing technologies
before we’re certain they’re safe and effective.”
Van
Blerkom respects Albertini’s research but expresses
reservations about his clinical ruminations. “If there were
really problems with manipulating eggs, you’d see it, and in
fact you’d have seen it 10 or 15 years ago,” said Van Blerkom.
“In the literature, there are only 26 reported cases of
imprinting-associated disorders with IVF, and that is out of
1.2 million IVF births.” In some hands, he added, ICSI is now
achieving fertilization rates of between 60 percent and 70
percent, even though the technique requires the removal of
surrounding cells. “If these cells were so important,” he
said, “you shouldn’t get such high pregnancy rates.”
Albertini
replied that there might be subtle health effects, such as
early onset of adult diseases like diabetes and cancer, that
won’t appear until 15 or 20 years after IVF, and he pointed
out that there is very little follow-up data on the health of
children created through assisted reproductive medicine. Even
Van Blerkom conceded that point. “There’s no systematic,
organized mechanism for follow-up,” he said. “And the reason
for that is that people don’t want it.”
It may
seem like an arcane debate, but it has life-and-death
ramifications every day, when IVF practitioners peer at egg
cells through microscopes and try to predict the fate of the
embryos they might become. IVF remains, at best, a hopeful art
driven by the best of intentions and less than complete
knowledge. About two weeks after he sorted through those eight
human eggs late one moonlit night, Van Blerkom called to
report, happily, that his initial hunch had been wrong.
“I’ve
got good news,” he announced. “She’s pregnant.” It was a
particularly felicitous way of acknowledging that, until
biology provides a better crystal ball, pregnancy remains the
best—and perhaps only—way to find out if an egg is
good.
Discuss this article in
the Discover Forum